
|Articles|January 10, 2005
New drug treats overactive bladder without drying mouth
Overactive bladder (OAB) affects approximately 17 million to 20 million people in the United States, yet few realize that it is a treatable condition. Many people believe that it is a natural part of the aging process and are embarrassed to discuss it. It is estimated that costs related to OAB were nearly $14 billion in this country in 2000, similar to that of gynecological and breast cancers, osteoporosis, or arthritis.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Expands Approval of Flibanserin for Postmenopausal Women’s Sexual Health
2
Why Trump’s Second Term is Different for the MFN Drug Pricing Policy
3
Pharmacists Can Play Central Role in Patients’ Infusion Services | ASHP Midyear 2025
4
Greater Coordination, Integration Necessary for Pregnant Women With Epilepsy
5




























































































































